Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

4.5%

1 terminated out of 22 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

55%

12 trials in Phase 3/4

Results Transparency

50%

6 of 12 completed with results

Key Signals

6 with results92% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (4)
Early P 1 (1)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (11)

Trial Status

Completed12
Not Yet Recruiting4
Withdrawn3
Terminated1
Recruiting1
Unknown1

Trial Success Rate

92.3%

Benchmark: 86.6%

Based on 12 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT07688512Phase 4Not Yet Recruiting

Oxytocin Bolus Versus Infusion in High-Risk Patients Undergoing Elective Cesarean Section (INBOX-HR)

NCT07217899Phase 2Recruiting

Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony

NCT06192836Completed

Placental Removal Method And Uterine Massage On Preventing Postpartum Hemorrhage

NCT07636421Phase 4Not Yet Recruiting

Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority Trial

NCT07609589Not ApplicableNot Yet Recruiting

Balloon Tamponade Versus Gauze Packing for Postpartum Hemorrhage

NCT07606846Not ApplicableNot Yet Recruiting

Exteriorization Versus In Situ Hysterotomy Repair During Cesarean: Effects on Uterine Tone

NCT02910115Not ApplicableTerminated

Cooling the Uterus in C-section After Dysfunctional Labor

NCT03413917CompletedPrimary

Exploration and Determination of Genomic Markers Predictive of Uterine Atony

NCT03584854Phase 4Completed

Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial

NCT05027048Phase 3CompletedPrimary

Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery

NCT03867383Phase 1CompletedPrimary

Calcium Chloride for Prevention of Uterine Atony During Cesarean

NCT04690153CompletedPrimary

Novel Approach of Hayman Uterine Compression Sutures for Management of Severe Atonic Postpartum Hemorrhage: Three Vertical Sutures

NCT03303235Early Phase 1WithdrawnPrimary

Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections

NCT02229513Not ApplicableCompleted

Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage

NCT02410655Phase 4WithdrawnPrimary

An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery

NCT01549223Phase 4CompletedPrimary

Oxytocin And Uterotonic Agent Use For Cesarean Delivery

NCT02780245Phase 4Completed

Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section

NCT00790062Phase 4CompletedPrimary

Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT

NCT01630187Phase 4CompletedPrimary

Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section

NCT01579201Phase 4Unknown

ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery

Scroll to load more

Research Network

Activity Timeline